Obstetrics & Gynecology Doctors in Keesler Afb, MS Accepting Medicare

3 Obstetrics & Gynecology doctors found. Showing 1 - 3

Yvonne Marie Sculley, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 301 Fisher St, Keesler Afb, MS 39534 Phone: 228-376-4118

Melissa Decker, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 301 Fisher St, Keesler Afb, MS 39534 Phone: 813-765-9301

Ashley Nicole Reid, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 301 Fisher St, Keesler Afb, MS 39534 Phone: 228-376-0433    Fax: 228-376-0172

News Archive

Study reveals structure of ribosomal assembly intermediate

As part of a joint research effort with the University of Michigan, scientists from the Florida campus of The Scripps Research Institute have for the first time defined the structure of one of the cell's most basic engines, which is required for cell growth, as it assembles from its components.

Age-related macular degeneration: an interview with Cathy Yelf, Macular Society

Age-related macular degeneration is a condition of the macula, a tiny area of the retina at the back of the eye. Your macula is only about the size of the grain of rice, that's about four millimeters across.

Review focuses on autologous cell therapy that can be applied to cardiac surgery

The combination of cell and gene therapy is rapidly raising clinical interest, although their combination has been under investigation for several decades. This is mainly due to the availability and feasibility of clinically relevant gene delivery options. This review focuses on cell therapies for heart failure and their use combined with cardiac surgery as well as with gene therapy.

Novavax reports positive preclinical results for H1N1 influenza VLP vaccine

Novavax, Inc. (Nasdaq: NVAX) announced positive preclinical results with Novavax's 2009 novel H1N1 influenza virus-like particle (VLP) vaccine. The study, conducted by scientists from Novavax and the Centers for Disease Control and Prevention (CDC) based in Atlanta, GA, under a collaborative agreement, represents the first efficacy report of a 2009 novel H1N1 vaccine in ferrets. The ferret model is widely accepted to be the most appropriate animal model for evaluating influenza disease and vaccines. Novavax scientists designed the vaccine using recombinant virus like particles (VLP) technology against an H1N1 virus strain (A/California/04/2009) isolated in the beginning of the 2009 H1N1 outbreak.

Read more Medical News

› Verified 6 days ago